UK markets close in 4 hours 26 minutes

Tissue Regenix Group plc (TRX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
61.05-0.45 (-0.73%)
As of 10:01AM BST. Market open.
Currency in GBp

Valuation measures4

Market cap (intra-day) 43.40M
Enterprise value 47.21M
Trailing P/E N/A
Forward P/E 112.36
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.83
Price/book (mrq)1.79
Enterprise value/revenue 1.60
Enterprise value/EBITDA 105.86

Trading information

Stock price history

Beta (5Y monthly) 1.47
52-week change 30.33%
S&P500 52-week change 321.08%
52-week high 372.94
52-week low 348.00
50-day moving average 364.55
200-day moving average 357.20

Share statistics

Avg vol (3-month) 366.76k
Avg vol (10-day) 339.63k
Shares outstanding 570.57M
Implied shares outstanding 670.57M
Float 845.15M
% held by insiders 146.75%
% held by institutions 153.51%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 328 Apr 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -5.81%
Operating margin (ttm)-1.04%

Management effectiveness

Return on assets (ttm)-0.55%
Return on equity (ttm)-5.55%

Income statement

Revenue (ttm)29.49M
Revenue per share (ttm)0.42
Quarterly revenue growth (yoy)21.80%
Gross profit (ttm)N/A
EBITDA 451k
Net income avi to common (ttm)-1.71M
Diluted EPS (ttm)-0.02
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.65M
Total cash per share (mrq)0.07
Total debt (mrq)9.39M
Total debt/equity (mrq)32.01%
Current ratio (mrq)4.03
Book value per share (mrq)0.43

Cash flow statement

Operating cash flow (ttm)1.04M
Levered free cash flow (ttm)-740.38k